ArticlemHealth2025
Micro-randomized pilot trial of an app-based smoking urge reduction intervention for young adults.
Article in mHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05991934 (Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Background: Cigarette smoking remains the leading preventable cause of illness and death in the United States and young adults are a priority population. This study aimed to investigate the feasibility of conducting a pilot micro-randomized trial (MRT) among young adults, using smartphone messages to reduce smoking urges in high-risk situations and combining Ecological Momentary Assessments (EMA) and geofence-based delivery. Methods: Participants were recruited online and completed surveys on Qualtrics and an EMA app to report smoking situations over 14 days (assessment phase). Assessment phase data were used to generate individual risk profiles [by combining timestamps, Global Positioning System (GPS), and self-reported data] with the highest likelihood of smoking for each participant. We used geofencing to generate geospatial buffers around these high-risk locations and intervention messages were triggered when a mobile device entered a geofence during specific time windows. In the following 30-day intervention phase, participants were prompted to complete up to 3 geofence-triggered EMAs daily. Each geofence-triggered EMA was followed by an intervention message and the type of message (distraction, acceptance, control) was randomized at each time point (within-subject). Urge level was the primary proximal outcome assessed in a follow-up EMA up to 15 minutes after message delivery. Analyses investigated the feasibility of study procedures, including geofence triggers, within-subject randomization, EMA survey completion rates, and smoking urge reports before and after message delivery. Cigarette smoking cessation and reduction outcomes at 45-day follow-up were also investigated. Results: A total of 8 participants were included in analyses (mean age 26.3 years; 50% male; 37.5% non-Hispanic White). In the assessment phase, participants completed between 4 and 51 real-time smoking reports. At least 2 geofences were created per participant, with a maximum of 9 geofences for one participant. In the intervention phase, between 11 and 90 geofence EMAs were triggered per participant. Compliance with EMAs was high (90.1% of geofence-triggered, 93.9% of follow-up EMAs). Within-subject randomization was successful and urge ratings declined from pre- to post-message assessments for control (k=98; mean difference =0.20), acceptance (k=99, mean difference =0.36) and distraction messages (k=94, mean difference =0.37). At 45-day follow-up, 1 participant (12.5%) reported no cigarette smoking during the past 7 days and abstinence was confirmed remotely using saliva cotinine testing. Half of participants (n=4, 50%) reduced their number of cigarettes per day (CPD) from baseline to follow-up by 50% or more. Findings also demonstrated the need for robust prevention of fraudulent research participant enrollment, as 10 participants were excluded due to GPS locations outside of the United States. Conclusions: Results indicate potential technical feasibility of an app-based MRT using intervention messages triggered by geofence locations. Findings will inform a fully powered MRT to investigate message efficacy to reduce smoking urges and smoking in young adults. Trial Registration: ClinicalTrials.gov (NCT05991934).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.